Literature DB >> 11064791

The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report.

P B Deaner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11064791     DOI： 10.1191/026921600701536110

Source DB:  PubMed          Journal:  Palliat Med        ISSN： 0269-2163            Impact factor:   4.762


× No keyword cloud information.
  2 in total

1.  Gabapentin in the treatment of severe sweating experienced by advanced cancer patients.

Authors:  Giampiero Porzio; Federica Aielli; Lucilla Verna; Claudio Porto; Paolo Aloisi; Katia Cannita; Enrico Ricevuto; Paolo Marchetti; Corrado Ficorella
Journal:  Support Care Cancer       Date:  2006-01-10       Impact factor: 3.603

2.  Familial secondary hyperhidrosis associated with tumor necrosis factor-alpha inhibitor treatment.

Authors:  Ogechi Ikediobi; Yi-Chun Chen; Kanade Shinkai
Journal:  JAAD Case Rep       Date:  2015-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.